Sol-Gel Technologies (SLGL) Prepaid Assets (2016 - 2026)
Sol-Gel Technologies' (SLGL) quarterly Prepaid Assets came in at $1.9 million in Q1 2026, down 28.45% year-on-year from $2.6 million in Q1 2025, and up 88.65% on a QoQ basis from $1.0 million in Q4 2025.
Sol-Gel Technologies (SLGL) Prepaid Assets (2016 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 11 years of Prepaid Assets data on file, last reported at $1.9 million in Q1 2026.
- On a quarterly basis, Prepaid Assets fell 28.45% year-over-year to $1.9 million in Q1 2026; TTM through Mar 2026 was $1.9 million, a 28.45% decrease from a year earlier, with the FY2025 full-year figure at $1.0 million, down 73.4% from the prior year.
- Prepaid Assets for Q1 2026 stood at $1.9 million, up from $1.0 million in the prior quarter.
- Over the last five years, Prepaid Assets for SLGL reached as high as $3.8 million in Q4 2024 and fell as low as $747000.0 in Q1 2022.
- Historically, Prepaid Assets has averaged $1.9 million across 5 years, with a median of $1.9 million in 2026.
- Across the five-year window, Prepaid Assets soared 88.62% in 2022 and sank 73.4% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $1.5 million in 2022, then soared by 85.16% to $2.8 million in 2023, then soared by 35.08% to $3.8 million in 2024, then sank by 73.4% to $1.0 million in 2025, then surged by 88.65% to $1.9 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $1.9 million in Q1 2026, $1.0 million in Q4 2025, and $962000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Sol-Gel Technologies | 227.58 Mn | 217.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.89 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 962,000.00 |
| Jun 30, 2025 | 1.94 Mn |
| Mar 31, 2025 | 2.65 Mn |
| Dec 31, 2024 | 3.77 Mn |
| Sep 30, 2024 | 2.88 Mn |
| Jun 30, 2024 | 1.75 Mn |
| Mar 31, 2024 | 2.12 Mn |
| Dec 31, 2023 | 2.79 Mn |
| Sep 30, 2023 | 2.15 Mn |
| Jun 30, 2023 | 2.41 Mn |
| Mar 31, 2023 | 1.13 Mn |
| Dec 31, 2022 | 1.51 Mn |
| Sep 30, 2022 | 1.47 Mn |
| Jun 30, 2022 | 1.69 Mn |
| Mar 31, 2022 | 747,000.00 |
| Dec 31, 2021 | 800,000.00 |
| Sep 30, 2021 | 1.17 Mn |
| Jun 30, 2021 | 1.56 Mn |